History

Objective: The objective of this study is to examine oligohydramnios as a predictor of maternal risk during term pregnancy and its impact on fetal outcomes. Study Design: cross-sectional study. Place and Duration: This study was conducted in Sandeman Provisional Hospital, Quetta from July 2022 to July 2023. Methodology All patients diagnosed with oligohydramnios were included through non-probability consecutive sampling technique. Informed consent was obtained from each participant after explaining the study's methodology. Demographic data, clinical characteristics, obstetrical complications, and delivery methods were documented. Maternal and newborn outcomes during inpatient care were observed and recorded. Results: The study sample's mean gestational age was 38.53 ? 2.13 weeks, and its mean age was 27.86 ? 4.42 years. The majority of women (82%) and patients (73%) both had normal weights and no concomitant conditions. Merely 9% reported having oligohydramnios during a prior pregnancy. The type of delivery used by 92% of the women in the research was caesarean section. In the Neonatal Intensive Care Unit (NICU), 15% of the newborns were admitted with a mean birth weight of 2.81 ? 0.52 kg. There was no statistically significant correlation (p-value > 0.05) between the mother's body mass index and the birth weight or the APGAR score at 1 and 5 minutes. Conclusions: Oligohydramnios, a common pregnancy complication, is associated with an increased risk of adverse postnatal outcomes, indicative of fetal compromise. Vigilant fetal surveillance, regular antenatal care, and appropriate interventions may contribute to reducing perinatal morbidity and mortality.